MedicarePartD.guide

A non-government resource built from CMS public data

Jynneos on SilverScript Choice (S5601-056)

vaccinia virus modified strain ankara-bavarian nordic non-replicating antigen

Covered, with prior authorization required.

Tier 1 (preferred generic). No quantity limit.

$0.00
Patient pays / month, after deductible
$0.00
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

JYNNEOS 50000000 1/.5mL Injection, Suspension at a preferred retail pharmacy.

Prior authRequired on the covered form· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-056